The signing ceremony took place within the framework of the 25th anniversary of Boehringer Ingelheim's presence in Vietnam, with the participation of representatives from the Ministry of Health, healthcare organizations, and media agencies.
The collaboration aims to improve diagnosis, treatment, and management of cardiovascular, renal, metabolic, pulmonary, and other non-communicable diseases, helping to reduce treatment costs, social costs, and contribute to improving the quality of life for patients.
The cooperation framework includes activities such as professional training and continuous medical education for doctors; support for diagnosis and improvement of treatment quality, disease management, and raising community awareness about diseases.
Associate Professor. Dr. Luong Ngoc Khue, Vice President of the National Medical Council, Head of Department of Medical Service Administration, welcomed and highly appreciated the collaboration of Boehringer Ingelheim, contributing to the implementation of the goal of improving the capacity and effectiveness of the Vietnamese healthcare system to better meet the healthcare needs of the entire population.
Ms. Cyndy Bautista-Galimpin, General Manager of Boehringer Ingelheim Vietnam, shared, "Boehringer Ingelheim is proud to join hands with the Vietnam Department of Medical Service Administration to promote advances in healthcare in Vietnam. This is part of our long-term commitment to contribute to addressing unmet medical needs and is in line with our purpose of Transforming Lives for Generations."
According to the the World Health Organization (WHO), non communicable diseases kill 41 million people each year or equivalent to 74% of all deaths. Of them, 77% are in low- and middle-income countries, including Vietnam. The number of Vietnamese with diabetes reached almost five million in 2021, equivalent to 7.1% of adults, according to the Ministry of Health.
